Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel node mapping for malignant melanoma.

M Landra1, F Acchiardi, F Pugno

  • 1First Department of General Surgery, Azienda Ospedaliera S. Croce, Cuneo, Italy. landra.m@scroce.sanitacn.it

Tumori
|October 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling transcriptional silencing and its coupling to 3D genome organisation.

Soft matter·2025
Same author

Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence.

Metabolomics : Official journal of the Metabolomic Society·2022
Same author

Direct Route to Colloidal UHMWPE by Including LLDPE in Solution during Homogeneous Polymerization of Ethylene.

ACS macro letters·2022
Same author

Unopposed estrogens: current and future perspectives.

European review for medical and pharmacological sciences·2022
Same author

Investigating site-selection mechanisms of retroviral integration in supercoiled DNA braids.

Journal of the Royal Society, Interface·2021
Same author

The use of D-chiro-Inositol in clinical practice.

European review for medical and pharmacological sciences·2021
Same journal

End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

Tumori·2026
Same journal

Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

Tumori·2026
Same journal

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

Tumori·2026
Same journal

Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

Tumori·2026
Same journal

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

Tumori·2026
Same journal

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Tumori·2026
See all related articles

Sentinel lymph node biopsy using methylene blue and 99mTc mapping identified tumor cells in 25% of melanoma patients. This aids in selecting treatment, balancing watchful waiting with radical surgery.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Malignant melanoma diagnosis and staging are critical for patient outcomes.
  • Sentinel lymph node biopsy (SLNB) is a key staging procedure for melanoma.
  • Accurate identification of involved lymph nodes impacts treatment decisions.

Purpose of the Study:

  • To evaluate the efficacy of a dual-tracer technique for sentinel lymph node biopsy in melanoma patients.
  • To determine the rate of metastasis in sentinel nodes for thicker melanomas.
  • To assess the utility of SLNB in guiding surgical management strategies.

Main Methods:

  • A cohort of 67 melanoma patients was reviewed.
  • Sentinel lymph nodes were identified in 26 patients with lesions >1 mm using methylene blue staining and 99mTc gamma probe mapping.

Related Experiment Videos

  • Forty-six sentinel nodes were surgically retrieved and pathologically examined.

    • Main Results:

    • The dual-tracer technique successfully identified sentinel lymph nodes in eligible patients.
    • Tumor cells were detected in 25% of the retrieved sentinel lymph nodes.
    • The findings support the use of SLNB for accurate melanoma staging.

    Conclusions:

    • Sentinel lymph node biopsy using combined methylene blue and radiotracer mapping is effective for melanoma staging.
    • Identification of metastatic melanoma in sentinel nodes allows for personalized treatment planning.
    • This technique helps differentiate patients who may benefit from observation versus more aggressive surgical intervention.